Baystate Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $637K | Buy |
5,844
+772
| +15% | +$80.1K | 0.05% | 123 |
|
|
2023
Q3 | $522K | Sell |
5,072
-1
| -0% | -$108 | 0.04% | 129 |
|
|
2023
Q2 | $585K | Sell |
5,073
-354
| -7% | -$40.2K | 0.05% | 121 |
|
|
2023
Q1 | $577K | Buy |
5,427
+383
| +8% | +$41.4K | 0.05% | 123 |
|
|
2022
Q4 | $560K | Buy |
5,044
+14
| +0.3% | +$1.43K | 0.05% | 131 |
|
|
2022
Q3 | $433K | Sell |
5,030
-30
| -0.6% | -$2.68K | 0.04% | 130 |
|
|
2022
Q2 | $461K | Buy |
5,060
+20
| +0.4% | +$1.77K | 0.04% | 127 |
|
|
2022
Q1 | $414K | Buy |
5,040
+20
| +0.4% | +$1.58K | 0.04% | 128 |
|
|
2021
Q4 | $385K | Buy |
5,020
+93
| +2% | +$7.41K | 0.03% | 127 |
|
|
2021
Q3 | $370K | Buy |
4,927
+221
| +5% | +$16.8K | 0.04% | 114 |
|
|
2021
Q2 | $366K | Buy |
4,706
+119
| +3% | +$8.85K | 0.04% | 111 |
|
|
2021
Q1 | $337K | Buy |
4,587
+124
| +3% | +$9.15K | 0.04% | 110 |
|
|
2020
Q4 | $348K | Sell |
4,463
-1,980
| -31% | -$151K | 0.04% | 96 |
|
|
2020
Q3 | $510K | Buy |
6,443
+25
| +0.4% | +$1.96K | 0.06% | 75 |
|
|
2020
Q2 | $474K | Buy |
6,418
+428
| +7% | +$32.2K | 0.06% | 77 |
|
|
2020
Q1 | $440K | Sell |
5,990
-99
| -2% | -$7.78K | 0.06% | 68 |
|
|
2019
Q4 | $528K | Buy |
6,089
+567
| +10% | +$46.6K | 0.06% | 62 |
|
|
2019
Q3 | $444K | Buy |
5,522
+105
| +2% | +$8.41K | 0.06% | 66 |
|
|
2019
Q2 | $436K | Sell |
5,417
-238
| -4% | -$18.2K | 0.06% | 67 |
|
|
2019
Q1 | $403K | Buy |
5,655
+173
| +3% | +$12.9K | 0.05% | 71 |
|
|
2018
Q4 | $397K | Buy |
5,482
+243
| +5% | +$17.2K | 0.06% | 66 |
|
|
2018
Q3 | $352K | Buy |
5,239
+95
| +2% | +$6.05K | 0.06% | 62 |
|
|
2018
Q2 | $304K | Sell |
5,144
-211
| -4% | -$11.9K | 0.05% | 68 |
|
|
2018
Q1 | $308K | Sell |
5,355
-1,707
| -24% | -$92.2K | 0.05% | 63 |
|
|
2017
Q4 | $413K | Sell |
7,062
-803
| -10% | -$44.5K | 0.06% | 57 |
|
|
2017
Q3 | $483K | Buy |
7,865
+1,084
| +16% | +$65.7K | 0.08% | 48 |
|
|
2017
Q2 | $405K | Buy |
6,781
+29
| +0.4% | +$1.76K | 0.07% | 48 |
|
|
2017
Q1 | $406K | Buy |
6,752
+222
| +3% | +$13.5K | 0.08% | 48 |
|
|
2016
Q4 | $375K | Buy |
+6,530
| New | +$382K | 0.07% | 42 |
|
|
2013
Q3 | – | Sell |
-2
| Closed | – | – | 154 |
|
|
2013
Q2 | $0 | Buy |
+2
| New | +$89 | ﹤0.01% | 287 |
|
Other funds holding MRK
Baystate Wealth Management's MRK Position: Q4 2023 in Review
Baystate Wealth Management increased its Merck (MRK) stake by 15% in Q4 2023, buying an estimated $80.1K and bringing the position to 5,844 shares worth $637K. The position accounts for 0.05% of the portfolio, ranked #123.
Baystate Wealth Management first reported a position in MRK in Q2 2013 and has held it in 30 quarters since. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.
- Baystate Wealth Management held 5,844 shares of Merck worth $637K as of Q4 2023.
- Baystate Wealth Management bought 772 Merck shares in Q4 2023, an estimated $80.1K.
- Merck made up 0.05% of Baystate Wealth Management's portfolio in Q4 2023, its #123 holding.
- Baystate Wealth Management first reported a position in Merck in Q2 2013 and has held it in 30 quarters since.
- 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.
Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.